Search research articles
Contact Us
Filters
Showing results (121-130 of 158) with videos related to
Page
of 16
Sort By:
European Journal of Heart Failure
|
April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans
Masatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Cardiovascular Imaging
|
December 15, 2023
Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy
Louhai Alwan, Dominik C Benz, Sarah A M Cuddy, et al.
JAMA Cardiology
|
March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study
Masatoshi Minamisawa, Brian Claggett, David Adams, et al.
Annals of Internal Medicine
|
January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study
Martha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
JACC. Cardiovascular Imaging
|
August 20, 2018
Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits
Paco E Bravo, Kana Fujikura, Marie Foley Kijewski, et al.
Circulation. Cardiovascular Imaging
|
November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis
Sarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 158) with videos related to
Sort By:
Page
of 16
European Journal of Heart Failure
|
April 30, 2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans
Masatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Cardiovascular Imaging
|
December 15, 2023
Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy
Louhai Alwan, Dominik C Benz, Sarah A M Cuddy, et al.
JAMA Cardiology
|
March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study
Masatoshi Minamisawa, Brian Claggett, David Adams, et al.
Annals of Internal Medicine
|
January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study
Martha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
JACC. Cardiovascular Imaging
|
August 20, 2018
Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits
Paco E Bravo, Kana Fujikura, Marie Foley Kijewski, et al.
Circulation. Cardiovascular Imaging
|
November 15, 2022
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis
Sarah Am Cuddy, Yesh Datar, Gavin Ovsak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 8, 2019
Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body <sup>18</sup>F-Florbetapir PET/CT
Eric C Ehman, M Samir El-Sady, Marie F Kijewski, et al.
JACC. Heart Failure
|
September 7, 2024
Functional Status and Quality of Life in Light-Chain Amyloidosis: Advanced Imaging, Longitudinal Changes, and Outcomes
Olivier F Clerc, Shilpa Vijayakumar, Sarah A M Cuddy, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Page
of 16